Skip to main content
Premium Trial:

Request an Annual Quote

Nexus Biosystems Acquires Aurora Biotechnologies

NEW YORK (GenomeWeb News) – Nexus Biosystems has acquired Aurora Biotechnologies for an undisclosed sum, Poway, Calif.-based Nexus said in a statement today.

Aurora makes high-performance microplates for use in sample storage, high-throughput screening, and cellular imaging. Nexus said that Aurora's technologies will complement its automated sample management systems, including its new -80degC BioStore line of sample management systems.

"As we head into 2010 with the Aurora technologies, we are very excited about the opportunity to expand our product reach beyond automated sample management into high throughput biochemical, cell-based and genomic screening applications," John Lillig, president and CEO of Nexus, said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.